WATSON 3449 20 mg (Morphine Sulfate Extended Release 20 mg)
Pill with imprint WATSON 3449 20 mg is Yellow & White, Capsule-shape and has been identified as Morphine Sulfate Extended Release 20 mg. It is supplied by Watson Laboratories, Inc..
Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for WATSON 3449 20 mg
Morphine Sulfate Extended Release
- Imprint:
- WATSON 3449 20 mg
- Strength:
- 20 mg
- Color:
- Yellow & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Watson Laboratories, Inc.
- Inactive Ingredients:
- corn starch
diethyl phthalate
ethylcelluloses
polyethylene glycol 6000
sucrose
povidone k30
magnesium silicate
ferric oxide black
gelatin
propylene glycol
titanium dioxide
D&C Yellow No. 10
hypromellose 2910 (5 mPa.s)
methacrylic acid - ethyl acrylate copolymer (1:1) type a
Note: Inactive ingredients may vary.
More about morphine
- Morphine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 312 Reviews
- Drug class: narcotic analgesics
Consumer resources
- Morphine
- Morphine Immediate-Release Tablets and Capsules
- Morphine Extended-Release Capsules
- Morphine Long-Acting Tablets
- Morphine Injection
- ... +6 more
Other brands: MS Contin, Roxanol, Kadian, MorphaBond ER, ... +8 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
